Haleon plc Stock

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 11:35:25 2024-06-06 am EDT 5-day change 1st Jan Change
331.3 GBX +1.07% Intraday chart for Haleon plc +2.03% +3.00%
Sales 2024 * 11.45B 14.65B Sales 2025 * 11.94B 15.28B Capitalization 29.94B 38.29B
Net income 2024 * 1.49B 1.91B Net income 2025 * 1.71B 2.19B EV / Sales 2024 * 3.3 x
Net Debt 2024 * 7.82B 10B Net Debt 2025 * 7.06B 9.03B EV / Sales 2025 * 3.1 x
P/E ratio 2024 *
20.3 x
P/E ratio 2025 *
17.6 x
Employees 25,408
Yield 2024 *
1.89%
Yield 2025 *
2.17%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.47%
1 week+1.60%
Current month+1.48%
1 month+0.98%
3 months+2.42%
6 months+1.82%
Current year+2.56%
More quotes
1 week
320.30
Extreme 320.3
330.80
1 month
320.30
Extreme 320.3
371.20
Current year
308.37
Extreme 308.3696
371.20
1 year
306.80
Extreme 306.8
371.20
3 years
241.17
Extreme 241.1735
371.20
5 years
241.17
Extreme 241.1735
371.20
10 years
241.17
Extreme 241.1735
371.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 64 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-06-06 331.3 +1.07% 10 140 922
24-06-05 327.8 +1.58% 12,742,960
24-06-04 322.7 -1.13% 16,289,630
24-06-03 326.4 +0.40% 13,342,480
24-05-31 325.1 +0.12% 51,827,680

Delayed Quote London S.E., June 06, 2024 at 03:37 am EDT

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.278 GBP
Average target price
3.646 GBP
Spread / Average Target
+11.24%
Consensus